Back to Journals » Vascular Health and Risk Management » Volume 16
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,213 | Dovepress* | 5,265+ | 1,308 | 6,573 | |
PubMed Central* | 948 | 330 | 1,278 | ||
Totals | 6,213 | 1,638 | 7,851 | ||
*Since 7 October 2020 |
View citations on PubMed and Google Scholar